---
title: "Metabolic dysfunction and biological aging jointly predict cardiometabolic multimorbidity risk"
id: "medrxiv-5-joint-contributions-of-metabolic-dysfunction-and-biological-aging-to"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-5-joint-contributions-of-metabolic-dysfunction-and-biological-aging-to"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1?rss=1"
published_at: "2026-08-26T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Metabolic dysfunction and biological aging jointly predict cardiometabolic multimorbidity risk
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-5-joint-contributions-of-metabolic-dysfunction-and-biological-aging-to
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1?rss=1)
- **Published At:** 2026-08-26T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This prospective cohort analysis used 8,767 CHARLS participants aged ≥45 years without cardiometabolic multimorbidity (CMM) at baseline to examine joint effects of metabolic dysfunction and **biological age** on CMM incidence and progression. - Baseline metabolic dysfunction was measured by the **triglyceride–glucose (TyG) index**; biological aging was quantified using two algorithms: Light BA and KDM BA. Biological age acceleration (BAA) was the residual of biological age regressed on chronological age. - Combined continuous TyG–BA composite indices were created as the product of TyG and biological age metrics. Cumulative exposure and two-wave trajectory analyses used repeated measures from 2011 and 2015. - Over a median follow-up of 108 months, 873 participants developed CMM. TyG and biological age were independently associated with incident CMM with mutually adjusted hazard ratios per SD increase of ~1.23–1.27 for TyG and ~1.39–1.44 for biological age. - Participants with both elevated TyG and accelerated biological aging had the highest CMM risk (HR 2.37 for Light BA; HR 2.26 for KDM BA) though no significant multiplicative interaction was observed. - Continuous TyG–BA composites were associated with 49%–62% higher CMM risk per SD increase; highest versus lowest quartile showed >3-fold higher risk and nonlinear dose–response relationships. - Higher cumulative exposure and elevated two-wave trajectory levels were linked to substantially increased CMM risk (HR range 3.93–5.17 comparing highest to lowest exposure groups). - Multistate models showed the composites were consistently associated with transitions across the cardiometabolic disease continuum and with mortality. - Adding TyG–BA composites to a prespecified clinical prediction model increased the C-index by 0.015–0.024 and improved net clinical benefit, but did not outperform a model retaining TyG and biological age as separate covariates. - Associations were stronger in younger and non-frail subgroups in exploratory analyses. Authors note that external validation is needed and emphasize potential utility of a **metabolic aging** framework for early risk stratification.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=mVG7g3Sg8nnUpNmiMk5_AIUGNC9MwXHKqiqlWs9wOrQ-1787779519.6304731-1.2.1.1-f7wOyx3aON.IkkYaDZuYMuPk6iK4g0rKMNdwPTZ5n3EV54XNEeqgc3VXgwMpFExQ) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Joint contributions of metabolic dysfunction and biological aging to cardiometabolic multimorbidity and disease progression: a prospective cohort study Baishuang Yang, Qiong Chen, Shasha Yang doi: https://doi.org/10.64898/2026.08.24.26361219 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Baishuang Yang Xiangya Hospital, Central South University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Baishuang%2BYang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yang%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABaishuang%2BYang%2B) Qiong Chen Xiangya Hospital, Central South University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Qiong%2BChen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chen%20Q&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AQiong%2BChen%2B) Shasha Yang Xiangya Hospital, Central South University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shasha%2BYang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yang%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AShasha%2BYang%2B) * For correspondence: yangshasha0901@163.com * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1286702/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1286702/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1286702/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1286702/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1286702/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1286702/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Cardiometabolic multimorbidity (CMM), which refers to having two or more cardiometabolic conditions like type 2 diabetes, stroke, and coronary heart disease, is becoming an increasing global health challenge. Although metabolic dysfunction and biological aging may jointly contribute to CMM development, most previous studies have examined these dimensions separately. Whether their combined assessment improves risk stratification and prediction across the cardiometabolic disease continuum remains unclear. Methods: This prospective cohort study involved 8,767 participants aged 45 and older who did not have CMM at the start, as part of the China Health and Retirement Longitudinal Study (CHARLS). Baseline evaluations included the triglyceride-glucose (TyG) index and two biological age algorithms, Light BA and KDM BA. The residual from regressing biological age on chronological age was used to derive BAA. Continuous TyG BA composite indices were constructed as the products of TyG and biological age. Cumulative exposure and two wave trajectory analyses used repeated measurements from 2011 and 2015. Multistate models examined associations across the cardiometabolic disease continuum. Cox proportional hazards models, along with restricted cubic splines and time dependent discrimination analyses, were utilized to examine associations, dose response relationships, and incremental predictive performance. Results: During a median follow-up span of 108 months, 873 participants were newly diagnosed with CMM. TyG and biological age were independently associated with CMM, with mutually adjusted hazard ratios of 1.23 to 1.27 and 1.39 to 1.44 per standard deviation increase, respectively. Individuals with elevated TyG and rapid biological aging faced the greatest CMM risk, showing hazard ratios of 2.37 for Light BA and 2.26 for KDM BA, despite the absence of a significant multiplicative interaction. Continuous TyG BA composites were associated with 49% to 62% higher CMM risk per standard-deviation increase, with more than threefold higher risk in the highest versus lowest quartile and nonlinear dose response relationships. Significantly increased CMM risk was linked to higher cumulative exposure and elevated two wave trajectory levels, with hazard ratios ranging from 3.93 to 5.17 when comparing the highest and lowest exposure groups. Multistate analyses demonstrated consistent associations of the composites with transitions across the cardiometabolic disease continuum and with mortality. Adding TyG BA composites to the prespecified clinical model increased the Cindex by 0.015 to 0.024 and improved net clinical benefit, but did not improve discrimination beyond models containing TyG and biological age as separate covariates. Associations were stronger in younger and non frail participants in exploratory subgroup analyses. Conclusions: Metabolic dysfunction and biological aging represent complementary dimensions of CMM susceptibility and progression. TyG BA composites provide a parsimonious summary of combined metabolic-aging burden and improve risk discrimination beyond conventional clinical factors, but should not be interpreted as superior to models retaining TyG and biological age separately. These findings support the potential utility of a metabolic aging framework for risk stratification and warrant external validation, particularly for its application in earlier stages of cardiometabolic disease development. Keywords: cardiometabolic multimorbidity; TyG index; biological age; metabolic aging composite; risk stratification; prospective cohort study ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Approval for the CHARLS study was granted by Peking University's Biomedical Ethics Review Committee (IRB00001052-11015), with all participants signing written informed consent forms I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data for this study were obtained from the CHARLS and are accessible via the project website (http://charls.pku.edu.cn) Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.25.26361320v1 "Temporal patterning of trigeminal nerve stimulation gates hippocampal plasticity across species")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.23.26361159v1 "Divergent climate suitability profiles for dengue and chikungunya transmission by Aedes albopictus in Mauritius") Posted August 26, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/26/2026.08.24.26361219.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.24.26361219v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/26/2026.08.24.26361219.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Joint contributions of metabolic dysfunction and biological aging to cardiometabolic multimorbidity and disease progression: a prospective cohort study Baishuang Yang, Qiong Chen, Shasha Yang medRxiv 2026.08.24.26361219; doi: https://doi.org/10.64898/2026.08.24.26361219 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361219v1%26text%3DJoint%2520contributions%2520of%2520metabolic%2520dysfunction%2520and%2520biological%2520aging%2520to%2520cardiometabolic%2520multimorbidity%2520and%2520disease%2520progression%253A%2520a%2520prospective%2520cohort%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361219v1%26t%3DJoint%2520contributions%2520of%2520metabolic%2520dysfunction%2520and%2520biological%2520aging%2520to%2520cardiometabolic%2520multimorbidity%2520and%2520disease%2520progression%253A%2520a%2520prospective%2520cohort%2520study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361219v1%26title%3DJoint%2520contributions%2520of%2520metabolic%2520dysfunction%2520and%2520biological%2520aging%2520to%2520cardiometabolic%2520multimorbidity%2520and%2520disease%2520progression%253A%2520a%2520prospective%2520cohort%2520study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361219v1%26title%3DJoint%2520contributions%2520of%2520metabolic%2520dysfunction%2520and%2520biological%2520aging%2520to%2520cardiometabolic%2520multimorbidity%2520and%2520disease%2520progression%253A%2520a%2520prospective%2520cohort%2520study "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.24.26361219) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.24.26361219v1&count=horizontal&via=&text=Joint%20contributions%20of%20metabolic%20dysfunction%20and%20biological%20aging%20to%20cardiometabolic%20multimorbidity%20and%20disease%20progression%3A%20a%20prospective%20cohort%20study&counturl=www.medrxiv.org/content/10.64898/2026.08.24.26361219v1 "Tweet This") ## Subject Area * [Endocrinology (including Diabetes Mellitus and Metabolic Disease) ](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (612) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (892) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4752) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (639) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1610) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15792) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6961) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (725) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1050) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4957) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1422) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1730) * [Hematology](https://www.medrxiv.org/collection/hematology) (577) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1328) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16226) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1157) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (661) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (717) * [Neurology](https://www.medrxiv.org/collection/neurology) (7156) * [Nursing](https://www.medrxiv.org/collection/nursing) (360) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1071) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1223) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (998) * [Oncology](https://www.medrxiv.org/collection/oncology) (3561) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1032) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (390) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (444) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (464) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1769) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (730) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5809) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9661) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2371) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1426) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1236) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (762) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (760) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (301) * [Urology](https://www.medrxiv.org/collection/urology) (285) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments
## Related Clinical Research

- [Metabolomic signatures of data-driven type 2 diabetes subtypes linked to dementia and mortality](https://medichelpline.com/clinical-feed/medrxiv-19-metabolomic-signatures-of-data-driven-type-2-diabetes-subtypes-and-their.md)
- [Nonlinear association of sleep quality (PSQI) with type 2 diabetes prevalence in community chronic](https://medichelpline.com/clinical-feed/plos-one-18-nonlinear-relationship-between-sleep-quality-and-prevalence-of-type-2-diabetes.md)
- [Adherence to Medications, Lifestyle Advice, and Self‑Monitoring for Type 2 Diabetes and Hypertensi](https://medichelpline.com/clinical-feed/plos-medicine-0-adherence-to-medications-lifestyle-advice-and-self-monitoring-for-type-2.md)
- [Semaglutide withdrawal strategies and recovery of cardiometabolic and energy-balance physiology: R](https://medichelpline.com/clinical-feed/plos-one-23-impact-of-semaglutide-withdrawal-on-cardiometabolic-profile-and-physiology-of.md)
- [Precision Insulin-Pump Calibration and Optimal Insulin Delivery to Reduce Postprandial Blood Gluco](https://medichelpline.com/clinical-feed/medrxiv-1-precision-insulin-pump-calibration-and-optimal-insulin-delivery-to-improve.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.